NDC 0409-1593

THAM

Tromethamine

THAM is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Tromethamine.

Product ID0409-1593_f74e6c85-e528-45a1-8ce6-8381540626c6
NDC0409-1593
Product TypeHuman Prescription Drug
Proprietary NameTHAM
Generic NameTromethamine
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-06-24
Marketing CategoryNDA / NDA
Application NumberNDA013025
Labeler NameHospira, Inc.
Substance NameTROMETHAMINE
Active Ingredient Strength4 g/100mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0409-1593-04

6 BOTTLE, GLASS in 1 CASE (0409-1593-04) > 500 mL in 1 BOTTLE, GLASS (0409-1593-14)
Marketing Start Date2020-06-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-1593-14 [00409159314]

THAM INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA013025
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-03-24
Marketing End Date2017-06-01

NDC 0409-1593-04 [00409159304]

THAM INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA013025
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-11-30
Marketing End Date2017-06-01

Drug Details


Trademark Results [THAM]

Mark Image

Registration | Serial
Company
Trademark
Application Date
THAM
THAM
88380252 not registered Live/Pending
Milla Pharmaceuticals, Inc.
2019-04-10
THAM
THAM
72109309 0730621 Dead/Cancelled
FISHER SCIENTIFIC COMPANY
1960-11-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.